Procter & Gamble Hygiene & Health Care Ltd. (PGHH) AI Stock Analysis

• Market Cap: ₹382.44B
• Dividend Yield: 2.08%
• Average Volume (3M): 854.00
• Price to Earnings (P/E): 44.5
• Beta (1Y): 0.36
• Revenue Growth: 8.28%
• EPS Growth: 11.65%
• Country: IN
• Employees: 439
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): 92.87
• Shares Outstanding: 32,460,735
• 10 Day Avg. Volume: 1,521
• 30 Day Avg. Volume: 854
• PEG Ratio: 2.02
• Price to Book (P/B): 59.85
• Price to Sales (P/S): 9.80
• P/FCF Ratio: 78.41
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 63 Neutral
• Price Target: ₹12,565.00 ▼(-1.02% Downside)

Procter & Gamble Hygiene & Health Care Ltd. demonstrates strong financial performance with consistent growth and profitability, which is the most significant factor in its overall score. The technical analysis indicates a bearish trend, and the valuation suggests the stock may be overvalued, slightly offsetting the strong financials. The absence of earnings call data and corporate events means these factors do not influence the score.

Positive Factors

Revenue & Margin Consistency

Sustained revenue expansion and stable gross/net margins indicate resilient demand for everyday health and hygiene products. This repeat-purchase business supports predictable cash flows, funds brand investment, and underpins long-term margin sustainability across economic cycles.

Low Leverage / Strong Balance Sheet

Minimal financial leverage provides durable financial flexibility to fund innovation, distribution expansion, or absorb shocks without costly refinancing. A strong capital structure supports long-term investment and preserves strategic optionality for growth initiatives.

Robust Cash Generation

Consistent free cash flow growth enables reinvestment in brands, working capital, and distributor reach while supporting shareholder returns. Strong OCF-to-income conversion enhances resilience and funds multi-year brand-building critical in FMCG.

Negative Factors

Product & Market Concentration

Concentration in a few categories and a single national market increases exposure to category-specific demand shifts, regulatory changes, or competitive moves. Limited diversification can constrain growth opportunities and amplify downside from structural shocks.

Erosion of Equity Buffer

A declining equity base, even if slight, reduces the capital cushion available to absorb losses or fund large strategic investments without external financing. Over time this can constrain balance sheet strength and limit risk-taking flexibility.

Dependence on P&G Affiliation

Reliance on group brand equity, know-how, and supply arrangements supports growth but leaves uncertainty around commercial/related-party terms. Unknown arrangements could affect margins or strategic autonomy if terms change, a persistent governance risk to monitor.

Procter & Gamble Hygiene & Health Care Ltd. Business Overview & Revenue Model

Company Description

Procter & Gamble Hygiene and Health Care Limited manufactures and sells branded packaged fast-moving consumer goods in the feminine care and healthcare businesses in India and internationally. The company provides health care products, including ointments and creams, cough drops, and tablets; and hygiene products, such as feminine hygiene and other skin care hygiene products, as well as feminine care pads. It also offers baby care products comprising nappies, pants, and baby wipes; laundry products; hair care products; home care products; and oral care products. The company offers its products under the Vicks, Whisper, Pampers, Ariel, Tide, Gillette, Head & Shoulders, Herbal Essences, Pantene, Ambi Pur, Oral-B, Olay, and Old Spice brand names. It sells its products through retail operations, including mass merchandisers, as well as grocery, membership club, drug, department, and high frequency stores. The company was incorporated in 1964 and is based in Mumbai, India. Procter & Gamble Hygiene and Health Care Limited is a subsidiary of Procter & Gamble Overseas India BV.

How the Company Makes Money

PGHH generates revenue through the sale of its wide array of hygiene and health care products, which are distributed through various channels including retail stores, e-commerce platforms, and direct sales. The company employs a business model centered around brand loyalty and market penetration, benefiting from established brand recognition and customer trust in its products. Key revenue streams include sales of personal care products like shampoos and skin care items, as well as health care products such as over-the-counter medicines and dietary supplements. Additionally, PGHH may engage in strategic partnerships with retailers and distributors to enhance product availability and visibility, contributing to its overall sales performance.

Procter & Gamble Hygiene & Health Care Ltd. Financial Statement Overview

Summary

Procter & Gamble Hygiene & Health Care Ltd. exhibits a strong financial position across all verticals. The income statement reflects consistent growth and profitability, the balance sheet indicates financial stability with low leverage, and the cash flow statement shows strong cash generation capabilities. The company is well-positioned to sustain its growth trajectory and manage potential risks effectively.

Income Statement

Procter & Gamble Hygiene & Health Care Ltd. demonstrates strong financial performance with consistent revenue growth and healthy profit margins. The gross profit margin remains robust, indicating efficient cost management, while the net profit margin shows solid profitability. The EBIT and EBITDA margins are stable, reflecting effective operational management. Overall, the income statement reflects a positive growth trajectory and profitability.

Balance Sheet

The company's balance sheet is characterized by a very low debt-to-equity ratio, indicating minimal leverage and financial stability. The return on equity is strong, showcasing effective utilization of shareholder funds to generate profits. The equity ratio is healthy, suggesting a solid capital structure. However, a slight decrease in stockholders' equity over the years could be a point of concern.

Cash Flow

The cash flow statement reveals a positive trend in free cash flow growth, indicating strong cash generation capabilities. The operating cash flow to net income ratio is healthy, suggesting efficient conversion of income into cash. The free cash flow to net income ratio is also strong, reflecting the company's ability to generate cash relative to its net income. Overall, the cash flow position is robust, supporting the company's operational and strategic initiatives.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	44.99B	44.99B	42.06B	39.05B	39.01B	35.70B
Gross Profit	25.48B	25.48B	25.76B	22.42B	17.17B	22.42B
EBITDA	12.11B	12.11B	10.22B	8.98B	8.43B	9.18B
Net Income	8.49B	8.49B	6.75B	6.78B	5.76B	6.52B
Balance Sheet
Total Assets	17.55B	17.55B	18.59B	21.37B	16.81B	16.33B
Cash, Cash Equivalents and Short-Term Investments	5.16B	5.16B	5.74B	9.64B	6.25B	6.48B
Total Debt	23.20M	23.20M	30.80M	40.30M	51.00M	34.70M
Total Liabilities	10.18B	10.18B	10.84B	11.91B	9.44B	9.18B
Stockholders Equity	7.37B	7.37B	7.75B	9.46B	7.38B	7.14B
Cash Flow
Free Cash Flow	5.63B	5.63B	4.26B	7.81B	5.23B	8.32B
Operating Cash Flow	6.18B	6.18B	4.71B	8.26B	5.73B	8.63B
Investing Cash Flow	-586.30M	-586.30M	10.60M	-99.10M	-268.50M	69.40M
Financing Cash Flow	-6.66B	-6.66B	-8.62B	-4.77B	-5.69B	-11.06B

Procter & Gamble Hygiene & Health Care Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 12694.65
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:PGHH, the sentiment is Negative. The current price of 12694.65 is above the 20-day moving average (MA) of 12278.76, above the 50-day MA of 12606.70, and below the 200-day MA of 13305.79, indicating a bearish trend. The MACD of -244.61 indicates Positive momentum. The RSI at 28.79 is Positive, neither overbought nor oversold. The STOCH value of 19.80 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:PGHH.

Procter & Gamble Hygiene & Health Care Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
COLPAL	70 Outperform	₹574.87B	43.32	―	2.42%	-2.06%	-9.74%
DABUR	66 Neutral	₹898.99B	48.68	―	1.62%	2.68%	1.07%
ZYDUSWELL	66 Neutral	₹141.82B	55.97	―	0.28%	14.55%	-20.61%
EMAMILTD	64 Neutral	₹212.25B	27.99	―	1.91%	0.84%	-2.44%
PGHH	63 Neutral	₹382.44B	44.50	―	2.08%	8.28%	11.65%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
GILLETTE	56 Neutral	₹286.64B	46.20	―	1.39%	7.42%	22.99%

Procter & Gamble Hygiene & Health Care Ltd. Corporate Events

P&G Hygiene & Health Care Declares Rs 195 Interim Dividend, Details TDS Rules for FY 2025-26

Procter & Gamble Hygiene and Health Care Limited’s board has declared an interim dividend of Rs 195 per equity share for FY 2025-26, which includes a one-time special dividend of Rs 25 per share, payable to shareholders on record as of February 5, 2026. In line with post-2020 tax rules that make dividends taxable in the hands of shareholders, the company has outlined applicable TDS provisions for resident investors and urged both demat and physical shareholders to update PAN, tax residency and contact details with depositories or the registrar so that the correct tax deduction at source rate can be applied, thereby affecting net dividend payouts and compliance requirements for investors.